Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

A new Gilead study shows that a single-tablet combo of HIV-fighting drugs could help patients who today take multiple drugs.

The trial evaluated treatment responses in patients who were virologically suppressed, switching from a multi-tablet regimen ...

Background “Prevention is better than cure,” they say. But what happens when prevention is no longer enough, when we have crossed that line and are confronted with the painful reality of a disease ...

Renovaro Inc. lost its initial bid to roll back part of its deal for a bogus HIV cure peddled by a Turkish conman later convicted of killing a blackmailer to keep the fraudulent transaction on track.

Today’s Liver Meeting presentation expands upon previous data among people living with HIV and MASLD finding that semaglutide improved weight, intra-hepatic triglyceride content, insulin resistance, ...

A Brazilian research team has eliminated HIV from a patient’s body for 78 consecutive weeks using only medications, without ...

Our nation's efforts to focus attention on the fight both in our country and throughout the globe is important if AIDS is ...

For more than 40 years, Dr. Gordon Crofoot has advanced HIV care through groundbreaking research, compassionate medicine, and ...

Gut bacteria influence HIV reservoir size and activity differently across GI segments, offering insights for targeted cure ...

Long-term, low doses of THC mitigate many harmful side effects and inflammation caused by HIV and antiretroviral therapy (ART ...

Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $103.7 million in ...